Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glycoprotein hormones, alpha polypeptide | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Toxoplasma gondii | intraflagellar transport protein 172, putative | glycoprotein hormones, alpha polypeptide | 116 aa | 94 aa | 26.6 % |
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | Protoporphyrinogen oxidase chloroplast/mitochondrial precursor | 0.0091 | 0.1125 | 0.1229 |
Plasmodium vivax | hypothetical protein, conserved | 0.0091 | 0.1125 | 0.5 |
Mycobacterium ulcerans | oxidoreductase | 0.0091 | 0.1125 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.045 | 0.9148 | 0.9148 |
Leishmania major | UDP-galactopyranose mutase | 0.0091 | 0.1125 | 0.5 |
Schistosoma mansoni | amine oxidase | 0.0091 | 0.1125 | 0.1229 |
Loa Loa (eye worm) | hypothetical protein | 0.0488 | 1 | 1 |
Trypanosoma cruzi | UDP-galactopyranose mutase | 0.0091 | 0.1125 | 0.5 |
Plasmodium falciparum | lysine-specific histone demethylase 1, putative | 0.0091 | 0.1125 | 0.5 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.0427 | 0.0427 |
Toxoplasma gondii | histone lysine-specific demethylase | 0.0091 | 0.1125 | 0.5 |
Onchocerca volvulus | 0.0488 | 1 | 0.5 | |
Plasmodium vivax | lysine-specific histone demethylase 1, putative | 0.0091 | 0.1125 | 0.5 |
Plasmodium falciparum | protoporphyrinogen oxidase | 0.0091 | 0.1125 | 0.5 |
Plasmodium vivax | protoporphyrinogen oxidase, putative | 0.0091 | 0.1125 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0129 | 0.1976 | 0.1976 |
Plasmodium falciparum | conserved Plasmodium protein, unknown function | 0.0091 | 0.1125 | 0.5 |
Chlamydia trachomatis | protoporphyrinogen oxidase | 0.0091 | 0.1125 | 0.5 |
Echinococcus multilocularis | lysine specific histone demethylase 1A | 0.045 | 0.9148 | 1 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0091 | 0.1125 | 0.5 |
Schistosoma mansoni | amine oxidase | 0.0091 | 0.1125 | 0.1229 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.0427 | 0.0427 |
Loa Loa (eye worm) | hypothetical protein | 0.0091 | 0.1125 | 0.1125 |
Toxoplasma gondii | histone lysine-specific demethylase LSD1/BHC110/KDMA1A | 0.0091 | 0.1125 | 0.5 |
Mycobacterium ulcerans | dehydrogenase | 0.0091 | 0.1125 | 0.5 |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.045 | 0.9148 | 1 |
Mycobacterium ulcerans | monoamine oxidase | 0.0091 | 0.1125 | 0.5 |
Mycobacterium leprae | PROBABLE PROTOPORPHYRINOGEN OXIDASE HEMY (PROTOPORPHYRINOGEN-IX OXIDASE) (PROTOPORPHYRINOGENASE) (PPO) | 0.0091 | 0.1125 | 0.5 |
Trypanosoma cruzi | UDP-galactopyranose mutase | 0.0091 | 0.1125 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0091 | 0.1125 | 0.1125 |
Plasmodium vivax | hypothetical protein, conserved | 0.0091 | 0.1125 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.045 | 0.9148 | 0.9148 |
Schistosoma mansoni | Lysine-specific histone demethylase 1 | 0.045 | 0.9148 | 1 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0091 | 0.1125 | 0.5 |
Mycobacterium ulcerans | protoporphyrinogen oxidase | 0.0091 | 0.1125 | 0.5 |
Mycobacterium tuberculosis | Possible oxidoreductase | 0.0091 | 0.1125 | 0.5 |
Brugia malayi | amine oxidase, flavin-containing family protein | 0.0129 | 0.1976 | 0.1976 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.0427 | 0.0427 |
Brugia malayi | hypothetical protein | 0.0091 | 0.1125 | 0.1125 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0091 | 0.1125 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0427 | 0.0427 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 3.1623 uM | PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 8.2753 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 20.5962 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 29.081 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.